HATTERAS VENTURE PARTNERS
HATTERAS VENTURE PARTNERS is a Pre-seed, Seed, Series A and Series C+ fund in Southeastern United States writing $500K–$5M checks into biopharmaceuticals, medical-devices, diagnostics and healthcare-tech.
- Stages
- Pre-seed, Seed, Series A, Series C+
- Sectors
- biopharmaceuticals, medical-devices, diagnostics, healthcare-tech
- Check size
- $500K–$5M
- Invests in
- Southeastern United States
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2000
- Assets under management
- $900M
- Website
- hatterasvp.com
Thesis
Hatteras Venture Partners, founded in 2000, is a venture capital firm focused on seed and early-stage investments in human medicine. The firm targets companies in biopharmaceuticals, medical devices, diagnostics, and health technology, addressing unmet medical needs. Hatteras is particularly active in the Southeastern United States. The firm manages over $900 million across seven venture funds and closed two new healthcare-focused funds in August 2025, totaling over $200 million. Hatteras applies a thesis-driven approach, focusing on high-impact healthcare innovations with strong scientific foundations and commercialization potential. They partner with entrepreneurs, offering capital, strategic guidance, operational expertise, and access to a healthcare network, participating as a lead investor in rounds and in board-level engagement.
Common questions
Does HATTERAS VENTURE PARTNERS invest at the Pre-seed stage?
Yes. HATTERAS VENTURE PARTNERS lists Pre-seed, Seed, Series A and Series C+ among the stages it invests in.
What check size does HATTERAS VENTURE PARTNERS write?
HATTERAS VENTURE PARTNERS writes $500K–$5M checks.
Where does HATTERAS VENTURE PARTNERS invest?
HATTERAS VENTURE PARTNERS invests in Southeastern United States.